Our technology is based on analysis of the human body’s natural 24-hour circadian cycles. These circadian cycles are driven by certain genes in our cells that regulate our metabolism. Those circadian cycles contain specific heat signatures and can be tracked metabolically.
It is well known that the formation of certain cancers, including in the breasts, are associated with disruption of circadian cellular genetic activity. While the circadian metabolic fluctuation in healthy tissue shows a wide profile, with tissue-invasive cancer, the disruption in the tissue’s metabolic processes causes the entire breast profile to flatten.
Our technology monitors changes in the metabolic profile over time. Thanks to the predictive power of our Artificial Intelligent foundation, within just a two hour segment our algorithms can distinguish between healthy and potentially cancerous metabolic profiles, no matter what your activity day or night. Our high rate of accuracy has been confirmed against actual patient pathology, not simply imaging interpretation.
The use of metabolic detection represents a breakthrough in cancer screening over image-based modalities such as mammography or ultrasound.
Much like a “snowflake in a snow storm”, interpretation of images in dense tissue can lead to cancers being missed, and to many unnecessary biopsies being conducted on non-cancerous tissue.
Many women are unaware that they have dense breasts and that their annual mammogram may miss the presence of cancer. Our technology does not rely on imaging, therefore we achieve the same levels of accuracy in detection regardless of breast tissue density, bring peace of mind to those women with dense tissue.
Our investigators believe the metabolic change we detect happens at the earliest stage of tumour formation in the tissue meaning that we can potentially find cancers when they are much smaller and more easily treatable. We can also distinguish, and rule out, other breast abnormalities that may appear as a suspicious lump on an image, but which are not invasive cancer.
Cancer detection by AI, not the naked eye.